Dr. Ramasubbaiah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3581 Palmer Drive suite 400
Cameron Park, CA 95682Phone+1 530-676-6600Fax+1 530-676-6673- Is this information wrong?
Summary
- Dr. Rashmi Ramasubbaiah is an oncologist in Cameron Park, CA and is affiliated with Marshall Medical Center. She received her medical degree from Sri Devaraj URS Medical College and has been in practice 18 years. She specializes in breast cancer, gastrointestinal cancer, and hematologic oncology.
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2010
- Carle Foundation HospitalResidency, Internal Medicine, 2004 - 2007
- Western Kentucky UniversityMS, Biology, microbiology, inmunology, Ooutstanding graduate student, 2001 - 2004
- Sri Devaraj URS Medical CollegeClass of 1999
Certifications & Licensure
- CA State Medical License 2013 - 2024
- MO State Medical License 2010 - 2014
- IL State Medical License 2007 - 2007
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Modular EHR, Cerner Corporation, 2013
Publications & Presentations
PubMed
- 61 citationsMiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer.John K. Chan, Tuyen K. Kiet, Kevin Blansit, Rashmi Ramasubbaiah, Joan F. Hilton, Daniel S. Kapp, Daniela Matei> ;Gynecologic Oncology. 2014 Jun 1
- 55 citationsPhase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101E. Gabriela Chiorean, Rashmi Ramasubbaiah, Menggang Yu, Joel Picus, Jose A. Bufill, Yan Tong, Nicki Coleman, Erica L. Johnston, Colleen Currie, Patrick J. Loehrer> ;The Oncologist. 2012 Jan 1
- Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group.Ramasubbaiah, R., Perkins, S. M., Schilder, J., Whalen, C., Johnson, C. S., Callahan, M., Jones, T., Sutton, G., Matei, D.> ;Gynecol Oncol. 2011 Dec
Professional Memberships
- Member
Hospital Affiliations
- Marshall Medical CenterPlacerville, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: